CIBA Vision, the eye care unit of Novartis, has announced a final global patent litigation settlement agreement with CooperVision, Inc. The agreement resolves all current patent infringement lawsuits between the two companies. CIBA Vision has licensed its Nicolson patents to CooperVision, while the latter company will pay the former a royalty on U.S. net sales of its Biofinity contact lenses until 2014 and on net sales outside the U.S. until 2016.